Literature DB >> 18333162

Viral hepatitis and the surgeon.

G Y Minuk1, A J Cohen, N Assy, M Moser.   

Abstract

BACKGROUND: Viral hepatitis is an infection of the liver caused by one or more of six known (HAV-HGV) hepatotropic viruses. It is a common problem among health care workers and their patients. Surgeons are at particular risk of both acquiring and transmitting some of these viruses from and to their patients. Unfortunately, specific immunoprophylaxis for viral hepatitis is presently limited to protecting against the spread of hepatitis A and B viral infections, leaving a high degree of vigilance and careful surgical technique as the only means available to prevent the transmission of other viruses relative to the surgeon. The purpose of this paper is to review the various forms of viral hepatitis including the nature of the virus, serologic testing, clinical features, epidemiology (with specific reference to those issues that arise in surgical practice), treatment and prevention.

Entities:  

Year:  2005        PMID: 18333162      PMCID: PMC2023923          DOI: 10.1080/13651820410016633

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  90 in total

1.  A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.

Authors:  R P Perrillo; E R Schiff; G L Davis; H C Bodenheimer; K Lindsay; J Payne; J L Dienstag; C O'Brien; C Tamburro; I M Jacobson; R Sampliner; D Feit; J Lefkowitch; M Kuhns; C Meschievitz; B Sanghvi; J Albrecht; A Gibas
Journal:  N Engl J Med       Date:  1990-08-02       Impact factor: 91.245

2.  Chronic viral hepatitis--benefits of current therapies.

Authors:  J H Hoofnagle; D Lau
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

3.  The delta agent.

Authors:  M Rizzetto
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

4.  Detection of HGV in serum and peripheral blood mononuclear cells of maintenance haemodialysis patients.

Authors:  M Basaras; E Arrese; F Cabrera; C Ezpeleta; R Cisterna
Journal:  J Hosp Infect       Date:  1999-06       Impact factor: 3.926

5.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

Authors:  C L Van der Poel; H T Cuypers; H W Reesink; A J Weiner; S Quan; R Di Nello; J J Van Boven; I Winkel; D Mulder-Folkerts; P J Exel-Oehlers
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

6.  Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela.

Authors:  S C Hadler; M De Monzon; A Ponzetto; E Anzola; D Rivero; A Mondolfi; A Bracho; D P Francis; M A Gerber; S Thung
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

7.  The prevalence of hepatitis C in a regional level I trauma center population.

Authors:  A J Kaplan; L K Zone-Smith; C Hannegan; E D Norcross
Journal:  J Trauma       Date:  1992-07

8.  Hepatitis C virus associated primary hepatocellular carcinoma in a noncirrhotic liver.

Authors:  W Herr; G Gerken; T Poralla; S Immenschuh; P Schirmacher; K W Steegmüller; H Schwickert; K H Meyer zum Büschenfelde
Journal:  Clin Investig       Date:  1993-01

9.  The low risk of hepatitis B in rural hospitals. Results of a seroepidemiologic survey.

Authors:  J R Harris; R F Finger; J M Kobayashi; S C Hadler; B L Murphy; R L Berkelman; K E Bussell
Journal:  JAMA       Date:  1984-12-21       Impact factor: 56.272

Review 10.  Occupational risk of infection with hepatitis B and hepatitis C virus.

Authors:  C N Shapiro
Journal:  Surg Clin North Am       Date:  1995-12       Impact factor: 2.741

View more
  4 in total

1.  Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey.

Authors:  Adebola T Olayinka; Akin Oyemakinde; Muhammad S Balogun; Anthonia Ajudua; Patrick Nguku; Moses Aderinola; Abiodun Egwuenu-Oladejo; Simeon W Ajisegiri; Samuel Sha'aibu; Bolanle O P Musa; Saheed Gidado; Abdulsalami Nasidi
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

2.  Seroprevalence of Hepatitis B Virus and Compliance to Standard Safety Precautions among Scavengers in Ilorin Metropolis, Kwara State, Nigeria.

Authors:  Rauf O Yusuf; Henry O Sawyerr; Adedotun T Adeolu; Lateefat M Habeeb; Tawakalitu T Abolayo
Journal:  J Health Pollut       Date:  2018-09-10

3.  Molecular epidemiology of hepatitis B virus genotypes in blood donors in Islamabad, Pakistan.

Authors:  Iram Masood; Usman Waheed; Muhammad Arshad; Muhammad Saeed; Ahmad Farooq; Sadaf Moneeba; Nosheen Basharat; Hasan Abbas Zaheer
Journal:  J Lab Physicians       Date:  2019 Jul-Sep

4.  Universal screening versus universal precautions in ophthalmic surgery.

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2018-03       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.